Incomplete financial disclosure in a study of cell-free hemoglobin-based blood substitutes and risks of myocardial infarction and death.
Natanson
Charles
C
D001802:Blood Substitutes / Q000009:adverse effects*; D006454:Hemoglobins / Q000009:adverse effects*; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology*
D001802:Blood Substitutes; D006454:Hemoglobins